Basket | Login | Register

 
 
 
 

ACI-35.030 (coming soon)

Phase II trials

Study Information

Name of the study

A study to evaluate the safety, tolerability and immunogenicity of Tau targeted vaccines in participants with early Alzheimer's disease

Study sponsor

AC Immune SA

Disease

Early Alzheimer's disease

Phase

Phase Ib/IIa

Information about the drug that will be tested in the studies

Name of the drug

ACI-35.030

Where and when will the study be conducted?

European countries involved in the trial (active)

  • Finland
  • The Netherlands

European country that will be involved in the trial (planned)

  • UK

Information for your doctor

Clinicaltrials.gov identifier

NCT04445831

Link to full text

https://clinicaltrials.gov/ct2/show/NCT04445831

 

 
 

Last Updated: Wednesday 11 November 2020

 

 
 

Options